MMF 250 HISUN Pill - blue & orange capsule/oblong, 19mm
Pill with imprint MMF 250 HISUN is Blue & Orange, Capsule/Oblong and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Hisun Pharmaceuticals USA, Inc.
Mycophenolate mofetil is used in the treatment of Organ Transplant, Rejection Prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MMF 250 HISUN
Mycophenolate Mofetil
- Imprint
- MMF 250 HISUN
- Strength
- 250 mg
- Color
- Blue & Orange
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Hisun Pharmaceuticals USA, Inc.
- Manufacturer
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- National Drug Code (NDC)
- 42658-0501
- Inactive Ingredients
-
croscarmellose sodium,
corn starch,
povidone k90,
magnesium stearate,
gelatin,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
More about mycophenolate mofetil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (59)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
- Mycophenolate mofetil oral/injection drug information
- Mycophenolate (Intravenous) (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Tablets
- Mycophenolate Mofetil Capsules
Other brands
Professional resources
- Mycophenolate monograph
- Mycophenolate (FDA)
- Mycophenolate Mofetil (FDA)
- Mycophenolate Mofetil Injection (FDA)
- Mycophenolate Suspension (FDA)
- Mycophenolate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
